{"id":"W4210418169","doi":"10.54194/digr6414","title":"Pharmacy scope of practice and access to Opioid Agonist Therapies (OAT) in Canada after COVID-19","year":2022,"lang":"en","type":"article","venue":"Canadian Health Policy","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Indivior","keywords":"Pharmacy; Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Scope (computer science); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Agonist; Medicine; Opioid epidemic; Opioid; Pharmacy practice; Buprenorphine; Pharmacology; Family medicine; Virology; Internal medicine; Receptor; Computer science; Disease; Infectious disease (medical specialty)","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002288575,0.0001442017,0.000309171,0.0005293299,0.0001979405,0.0000194856,0.0001471313,0.00001470489,0.0004257009],"category_scores_gemma":[0.0002975444,0.0001549354,0.00002022783,0.000662148,0.0000321652,0.00008662278,0.00007665963,0.0001990853,0.000003022386],"about_ca_system_candidate":true,"about_ca_system_consensus":true,"about_ca_system_score_codex":0.01051749,"about_ca_system_score_gemma":0.1184128,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9999447,"about_ca_topic_score_gemma":0.9996786,"domain_scores_codex":[0.998418,0.0001716299,0.0003188064,0.0002676896,0.0002465743,0.0005772853],"domain_scores_gemma":[0.9974234,0.0001172061,0.00009801647,0.0002783138,0.00004288089,0.002040151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001509305,0.0003910004,0.6161616,0.002497735,0.0002532523,0.002219886,0.05648122,0.0003221741,0.00002452064,0.001306127,0.2578999,0.06093331],"study_design_scores_gemma":[0.001637759,0.0001966622,0.1839678,0.00003579488,0.00001683484,0.00006179709,0.002757794,0.000007627148,0.00001599165,0.00002680998,0.8111483,0.0001267901],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5065465,0.00880808,9.237226e-7,0.4810131,0.0001441106,0.001495608,0.0009090818,0.00001033602,0.001072232],"genre_scores_gemma":[0.7379462,0.0008257228,0.00007515884,0.2606601,0.00005715343,0.0002725004,0.00004222425,0.00002133793,0.00009963832],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5532485,"threshold_uncertainty_score":0.9932809,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03968635140387691,"score_gpt":0.4128316845416423,"score_spread":0.3731453331377654,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}